2024 SUMMARY IN GOFARM
With new energy and optimism we start 2025! We are exposed to risk and risk of an event and to further development as a substance expert of devices.
We received a response – from our client, Partner, Supplier – for trust and control in 2024, which were approved by our goals and intention.
See in a nutshell what infection in our company!
1. Regulatory Challenges and Successes
In 2024, Gofarm focused on adapting its products – medical devices to the regulatory requirements of MDR 2017/745.
In March 2024, we signed an agreement with the notified body PCBC SA for MDR certification of the entire Gofarm portfolio, which includes over 30 medical devices!
Thanks to the hard work and expert knowledge of the Registration team, 4 certification audits were successfully completed, covering the first 13 Gofarm medical devices: including sea water, a nasal and sinus rinse kit, vaginal gel and a new dry and wet cough syrup.
Already in the first quarter of 2025, we expect MDR certificates and invite new customers to Private Label cooperation, offering the largest line of medical devices in Poland in the Ear/Throat/Nose (ENT) category.
2. Practically about new legal regulations
In June 2024, Gofarm, as the first company in Poland in the Private Label model for substance-based medical devices, organized a practical webinar on the new MDR 2017/745 regulations, which enjoyed great interest among both current and future clients, as well as experts from notified bodies and law firms. In the quarterly “Świat Przemysłu Farmaceutyczny” (issue 2/2024), we presented the regulatory opportunities and challenges for substance-based medical devices.
The article is also available online (p. 106) > LINK.
3. Development of the Gofarm product portfolio on international markets
Gofarm continued its international expansion and the establishment of new business relationships by participating as an exhibitor – for the sixth time – in the largest pharmaceutical fair in Europe – CPHI Worldwide Milan, as well as in the first edition of the CPHI Middle East fair in Riyadh. The company also promoted its portfolio in Thailand during the Vitafoods Asia fair, as well as at conferences in Paris and Madrid. We are proud that Gofarm products are sold in as many as 54 countries around the world!
4. Investments in research and development
Gofarm is developing its laboratories: R&D and analytical, investing in modern equipment, which is used for development work on new products. We specialize in pharmaceutical forms such as: syrups, drops, liquids, creams, gels, powders. We are currently starting R&D work for solid forms (tablets).
5. New product lines and development of the Private Label PRO model
In 2024, Gofarm expanded its portfolio with two new product lines: Procto Care and Gastro Balans. The company strengthened its business model as the originator of the Private Label PRO model, offering comprehensive, innovative and professional regulatory service for its customers from around the world. We deliver modern and safe medical products, while providing regulatory service at the highest level.
